Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Eli Lilly’s Zepbound shows promise as a sleep apnea treatment in late-stage trials By: CNBC.com News April 17, 2024 at 06:16 AM EDT The pharmaceutical giant plans to present the trial data at an upcoming medical conference and submit them to the U.S. Food and Drug Administration mid-year. Read More >> Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Eli Lilly’s Zepbound shows promise as a sleep apnea treatment in late-stage trials By: CNBC.com News April 17, 2024 at 06:16 AM EDT The pharmaceutical giant plans to present the trial data at an upcoming medical conference and submit them to the U.S. Food and Drug Administration mid-year. Read More >>